SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-058097
Filing Date
2017-10-26
Accepted
2017-10-26 21:25:52
Documents
2
Period of Report
2017-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1508
2 EX-24 DOCUMENT attachment1.txt EX-24 3047
  Complete submission text file 0001209191-17-058097.txt   5954
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Hunt Andrea (Reporting) CIK: 0001720487 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 171157746